- Filed
- May 22, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2026 · May 8, 2026 | 141.19M sh |
| Shares Diluted | FY 2026 · Mar 31, 2026 | 142.63M sh |
| Shares Diluted | FY 2026 · Mar 31, 2025 | 129.77M sh |
| Shares Diluted | FY 2026 · Mar 31, 2024 | 121.11M sh |
| Stock Repurchased | FY 2026 · Mar 31, 2026 | $1.85M |
| Stock Repurchased | FY 2026 · Mar 31, 2025 | $0 |
| Stock Repurchased | FY 2026 · Mar 31, 2024 | $0 |
| Capex | FY 2026 · Mar 31, 2026 | $3.68M |
| Capex | FY 2026 · Mar 31, 2025 | $2.4M |
| Capex | FY 2026 · Mar 31, 2024 | $2.65M |
| Operating Cash Flow | FY 2026 · Mar 31, 2026 | $55.79M |
| Operating Cash Flow | FY 2026 · Mar 31, 2025 | $63.55M |
| Operating Cash Flow | FY 2026 · Mar 31, 2024 | $78.99M |
| Long Term Debt | FY 2026 · Mar 31, 2026 | $282.26M |
| Long Term Debt | FY 2026 · Mar 31, 2025 | $338.37M |
| Short Term Debt | FY 2026 · Mar 31, 2026 | $39.22M |
| Short Term Debt | FY 2026 · Mar 31, 2025 | $11.59M |
| Cash And Equivalents | FY 2026 · Mar 31, 2026 | $93.26M |
| Cash And Equivalents | FY 2026 · Mar 31, 2025 | $88.05M |
| Cash And Equivalents restated | FY 2026 · Mar 31, 2024 | $116.3M |
| Stockholders Equity | FY 2026 · Mar 31, 2026 | $146.61M |
| Stockholders Equity | FY 2026 · Mar 31, 2025 | $122.2M |
| Stockholders Equity | FY 2026 · Mar 31, 2024 | $101.96M |
| Stockholders Equity | FY 2026 · Mar 31, 2023 | $99.91M |
| Current Liabilities | FY 2026 · Mar 31, 2026 | $192.86M |
| Current Liabilities | FY 2026 · Mar 31, 2025 | $169.24M |
| Total Liabilities | FY 2026 · Mar 31, 2026 | $516.21M |
| Total Liabilities | FY 2026 · Mar 31, 2025 | $560.97M |
| Current Assets | FY 2026 · Mar 31, 2026 | $209.81M |
| Current Assets | FY 2026 · Mar 31, 2025 | $203.87M |
| Total Assets | FY 2026 · Mar 31, 2026 | $662.82M |
| Total Assets | FY 2026 · Mar 31, 2025 | $683.18M |
| Eps Diluted | FY 2026 · Mar 31, 2026 | $0.01 |
| Eps Diluted | FY 2026 · Mar 31, 2025 | −$0.21 |
| Eps Diluted | FY 2026 · Mar 31, 2024 | −$0.56 |
| Eps Basic | FY 2026 · Mar 31, 2026 | $0.01 |
| Eps Basic | FY 2026 · Mar 31, 2025 | −$0.21 |
| Eps Basic | FY 2026 · Mar 31, 2024 | −$0.56 |
| Rd Expense | FY 2026 · Mar 31, 2026 | $112.98M |
| Rd Expense | FY 2026 · Mar 31, 2025 | $123.21M |
| Rd Expense | FY 2026 · Mar 31, 2024 | $136.22M |
| Net Income | FY 2026 · Mar 31, 2026 | $1.65M |
| Net Income | FY 2026 · Mar 31, 2025 | −$27.21M |
| Net Income | FY 2026 · Mar 31, 2024 | −$67.59M |
| Operating Income | FY 2026 · Mar 31, 2026 | $18.94M |
| Operating Income | FY 2026 · Mar 31, 2025 | $15.19M |
| Operating Income | FY 2026 · Mar 31, 2024 | −$27.6M |
| Gross Profit | FY 2026 · Mar 31, 2026 | $475.05M |
| Gross Profit | FY 2026 · Mar 31, 2025 | $485.27M |
| Gross Profit | FY 2026 · Mar 31, 2024 | $503.8M |
| Cost Of Revenue | FY 2026 · Mar 31, 2026 | $260.7M |
| Cost Of Revenue | FY 2026 · Mar 31, 2025 | $229.8M |
| Cost Of Revenue | FY 2026 · Mar 31, 2024 | $224.91M |
| Revenue | FY 2026 · Mar 31, 2026 | $735.75M |
| Revenue | FY 2026 · Mar 31, 2025 | $715.07M |
| Revenue | FY 2026 · Mar 31, 2024 | $728.71M |